Definitive chemoradiotherapy in Stage III nonsmall cell lung cancer: Turkey experience

Yilmaz, Ufuk; Yilmaz, Ulku; Yasar, Zehra; Kirakli, Esra; Ulger, Sukran; Ozdogan, Yasemin; DEMİRCİ, NİLGÜN; Erol, Serhat; Ozdogan, Ilker; Sahin, Burcu; KÖKSAL, DENİZ; Akcay, Cimen

doi:10.4103/0973-1482.163682

Definitive chemoradiotherapy in Stage III nonsmall cell lung cancer: Turkey experience

Yilmaz U., Yilmaz U., Yasar Z., Kirakli E. K., Ulger S., Ozdogan Y., ...Daha Fazla

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, cilt.12, sa.1, ss.334-339, 2016 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 12 Sayı: 1
Basım Tarihi: 2016
Doi Numarası: 10.4103/0973-1482.163682
Dergi Adı: JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.334-339
Hacettepe Üniversitesi Adresli: Evet

Özet

Aim: Concurrent chemoradiotherapy (CRT) is the standard therapy for patients with unresectable Stage III nonsmall cell lung cancer (NSCLC). The aim of this study was to assess the efficacy and safety of concurrent CRT in unresectable Stage III NSCLC in Turkey.